• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Zoll Medical discloses email phishing attack and potential data breach

Zoll Medical discloses email phishing attack and potential data breach

December 19, 2023 By Jim Hammerand

Zoll logoZoll Medical Corp. said a cyberattack may have exposed protected health information of current and former employees, dependants and beneficiaries.

Chelmsford, Massachusetts-based Zoll — an Asahi Kasei company — characterized the incident as a “sophisticated email phishing attack” that targeted a Zoll employee.

Phishing attacks use seemingly trustworthy communications via emails, text messages or even phone calls to get the recipient to share security information such as passwords or to open a malicious hyperlink or attachment.

“This incident was limited to emails and had no impact on Zoll’s medical devices, software, or services,” the company said in a news release. “The PHI affected by the incident varied by individual and may have included some individuals’ names, addresses, Social Security numbers, and protected health information and/or health insurance information.”

Zoll said it has no indication that the information has been misused, but that it will notify affected individuals by mail and offer free credit monitoring and identity theft protection services. A dedicated call center for the incident at 800-459-4255 is open from 8 a.m. to 8 p.m. Central time on weekdays, except for major U.S. holidays.

Zoll said it is also evaluating its cybersecurity education and training measures for employees.

In January, Zoll disclosed a cyberattack that potentially exposed PHI and other personal information for more than 1 million people. At the time, the company said it would enhance its data security practices. The company now faces litigation from patients affected by that data breach.

Zoll makes advanced emergency care devices that provide defibrillation and cardiac monitoring, circulation enhancement and CPR feedback, supersaturated oxygen therapy and ventilation.

Other medical device manufacturers have been hit by cyberattacks this year, most notably Henry Schein and LivaNova. In April, the FDA launched new cybersecurity requirements for developers and manufacturers of cyber devices.

Medical Design & Outsourcing: Henry Schein’s cyberattack offers lessons for others

Filed Under: Business/Financial News, Featured, Health Information Technology, News Well, Software / IT Tagged With: Asahi Kasei, cyberattack, Cybersecurity, phishing, Zoll Medical

More recent news

  • Sequel Med Tech’s automated twiist pump scores FDA clearance in type 2 diabetes
  • FDA posts alert for Edwards Lifesciences mitral valve delivery system after patient death
  • Former Medtronic RDN leader joins Teleflex
  • CMR Surgical CEO outlines the path forward for Stryker’s robotics partnership
  • Stryker earns FDA clearance for new bone and soft tissue removal platform

About Jim Hammerand

Jim Hammerand is the managing editor of Arrowfly's MassDevice and Medical Design & Outsourcing, where he leads coverage of medtech innovation, design, engineering and manufacturing. He also contributes to our Devicetalks podcasts and live events. Hammerand has more than two decades of journalism experience spanning newspapers, magazines, websites, live events, radio and TV news. For nearly a decade, Hammerand reported and edited business news for American City Business Journals as a reporter and digital editor at the Minneapolis/St. Paul Business Journal and then as managing editor of the Puget Sound Business Journal in Seattle. He holds degrees in journalism and management from the University of Minnesota and has won journalism awards from the Society of Professional Journalists, American Society of Business Publication Editors, and Trade, Association, Business Publications International. Connect with him on LinkedIn or by email at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy